266 related articles for article (PubMed ID: 33097793)
1. A cell cycle-dependent CRISPR-Cas9 activation system based on an anti-CRISPR protein shows improved genome editing accuracy.
Matsumoto D; Tamamura H; Nomura W
Commun Biol; 2020 Oct; 3(1):601. PubMed ID: 33097793
[TBL] [Abstract][Full Text] [Related]
2. Cas9-Geminin and Cdt1-fused anti-CRISPR protein synergistically increase editing accuracy.
Matsumoto D; Kishi K; Matsugi E; Inoue Y; Nigorikawa K; Nomura W
FEBS Lett; 2023 Apr; 597(7):985-994. PubMed ID: 36905332
[TBL] [Abstract][Full Text] [Related]
3. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
4. Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila.
Gratz SJ; Ukken FP; Rubinstein CD; Thiede G; Donohue LK; Cummings AM; O'Connor-Giles KM
Genetics; 2014 Apr; 196(4):961-71. PubMed ID: 24478335
[TBL] [Abstract][Full Text] [Related]
5. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
[TBL] [Abstract][Full Text] [Related]
6. Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair.
Schubert MS; Thommandru B; Woodley J; Turk R; Yan S; Kurgan G; McNeill MS; Rettig GR
Sci Rep; 2021 Sep; 11(1):19482. PubMed ID: 34593942
[TBL] [Abstract][Full Text] [Related]
7. Disabling Cas9 by an anti-CRISPR DNA mimic.
Shin J; Jiang F; Liu JJ; Bray NL; Rauch BJ; Baik SH; Nogales E; Bondy-Denomy J; Corn JE; Doudna JA
Sci Adv; 2017 Jul; 3(7):e1701620. PubMed ID: 28706995
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein.
Dong D; Guo M; Wang S; Zhu Y; Wang S; Xiong Z; Yang J; Xu Z; Huang Z
Nature; 2017 Jun; 546(7658):436-439. PubMed ID: 28448066
[TBL] [Abstract][Full Text] [Related]
9. Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing.
Tatiossian KJ; Clark RDE; Huang C; Thornton ME; Grubbs BH; Cannon PM
Mol Ther; 2021 Mar; 29(3):1057-1069. PubMed ID: 33160457
[TBL] [Abstract][Full Text] [Related]
10. Strong and tunable anti-CRISPR/Cas activities in plants.
Calvache C; Vazquez-Vilar M; Selma S; Uranga M; Fernández-Del-Carmen A; Daròs JA; Orzáez D
Plant Biotechnol J; 2022 Feb; 20(2):399-408. PubMed ID: 34632687
[TBL] [Abstract][Full Text] [Related]
11. Precision Genome Editing with CRISPR-Cas9.
Rahman S; Ikram AR; Azeem F; Tahir Ul Qamar M; Shaheen T; Mehboob-Ur-Rahman
Methods Mol Biol; 2024; 2788():355-372. PubMed ID: 38656525
[TBL] [Abstract][Full Text] [Related]
12. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
13. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.
Jain S; Xun G; Abesteh S; Ho S; Lingamaneni M; Martin TA; Tasan I; Yang C; Zhao H
ACS Synth Biol; 2021 Jun; 10(6):1320-1327. PubMed ID: 34006094
[TBL] [Abstract][Full Text] [Related]
14. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
Liu L; Yin M; Wang M; Wang Y
Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
[TBL] [Abstract][Full Text] [Related]
15. Precision genome editing in the CRISPR era.
Salsman J; Dellaire G
Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
[TBL] [Abstract][Full Text] [Related]
16. Optical Control of Genome Editing by Photoactivatable Cas9.
Otabe T; Nihongaki Y; Sato M
Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
Jayavaradhan R; Pillis DM; Goodman M; Zhang F; Zhang Y; Andreassen PR; Malik P
Nat Commun; 2019 Jun; 10(1):2866. PubMed ID: 31253785
[TBL] [Abstract][Full Text] [Related]
18. Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.
Yang H; Ren S; Yu S; Pan H; Li T; Ge S; Zhang J; Xia N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899704
[TBL] [Abstract][Full Text] [Related]
19. Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells.
Donohoue PD; Pacesa M; Lau E; Vidal B; Irby MJ; Nyer DB; Rotstein T; Banh L; Toh MS; Gibson J; Kohrs B; Baek K; Owen ALG; Slorach EM; van Overbeek M; Fuller CK; May AP; Jinek M; Cameron P
Mol Cell; 2021 Sep; 81(17):3637-3649.e5. PubMed ID: 34478654
[TBL] [Abstract][Full Text] [Related]
20. A Cas9-transcription factor fusion protein enhances homology-directed repair efficiency.
Li G; Wang H; Zhang X; Wu Z; Yang H
J Biol Chem; 2021; 296():100525. PubMed ID: 33689695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]